You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cholangiocarcinoma

Showing 26 - 50 of 1,049
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial (Camrelizumab, Gemcitabine Injection, Cisplatin injection)

Not yet recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • (no location specified)
Feb 17, 2023

Lymph Node Metastasis Status of Hilar Cholangiocarcinoma

Recruiting
  • Hilar Cholangiocarcinoma
  • No interventions
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 16, 2022

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Unresectable Intrahepatic Cholangiocarcinoma Trial in Baltimore (Durvalumab, SNDX-6352)

Active, not recruiting
  • Unresectable Intrahepatic Cholangiocarcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 10, 2023

Perihilar Cholangiocarcinoma Trial (Endobiliary radiofrequency ablation (eRFA), uncovered self-expanding metal stent (uSEMS))

Recruiting
  • Perihilar Cholangiocarcinoma
  • Endobiliary radiofrequency ablation (eRFA)
  • uncovered self-expanding metal stent (uSEMS)
  • Amsterdam, Netherlands
    Amsterdam UMC location VUmc
Oct 25, 2022

Drug Sensitivity of Patient-Derived Organoid Model From

Recruiting
  • Cholangiocarcinoma
  • No interventions.
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 29, 2022

Cholangiocarcinoma With IDH1 Mutation, Solid Tumors With IDH1 Mutation Trial in Beijing (AB-218 capsule)

Not yet recruiting
  • Cholangiocarcinoma With IDH1 Mutation
  • Solid Tumors With IDH1 Mutation
  • AB-218 capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Apr 2, 2023

Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis Trial in Tianjin (Durvalumab, Surgery, Gemcitabine)

Recruiting
  • Durvalumab
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jan 3, 2023

Cholangiocarcinoma, Bile Duct Cancer Trial in Toronto (Trifluridine/Tipiracil)

Terminated
  • Cholangiocarcinoma
  • Bile Duct Cancer
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Nov 28, 2022

Cholangiocarcinoma Trial (Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy)

Not yet recruiting
  • Cholangiocarcinoma
  • Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy
  • (no location specified)
Nov 10, 2022

Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Sep 7, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +5 more
  • Bintrafusp Alfa
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 22, 2023

Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)

Recruiting
  • Cholangiocarcinoma
  • High Dose Radiation
  • Systemic chemotherapy
  • Navi Mumbai, Maharashtra, India
    Advanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022

Intrahepatic Cholangiocarcinoma Trial in Oslo (Liver Transplant)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Oslo, Norway
    Oslo University Hospital
Oct 4, 2022

Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant Trial (SynKIR-110, Autologous T cells Transduced with

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
  • (no location specified)
Oct 5, 2022

Extrahepatic Cholangiocarcinoma, Malignant Biliary Obstruction Trial in Hangzhou (Spyglass + RFA, Cytobrush + RFA)

Enrolling by invitation
  • Extrahepatic Cholangiocarcinoma
  • Malignant Biliary Obstruction
  • Spyglass + RFA
  • Cytobrush + RFA
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Aug 9, 2022

Bile Duct Cancer, Cholangiocarcinoma, Cholangiocarcinoma Non-resectable Trial in Boston (Gemcitabine, Cisplatin, Durvalumab)

Not yet recruiting
  • Bile Duct Cancer
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 23, 2023

Cholangiocarcinoma on Choledochal Cyst in a Western Center

Recruiting
  • Incidence of Cholangiocarcinoma on Choledochal Cysts
  • +2 more
    • Huelva, Spain
      Juan Ramón Jimenez Hospital
    Oct 12, 2022

    Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

    Active, not recruiting
    • Cholangiocarcinoma
    • Shanghai, Shanghai, China
      Zhongshan Hospital Affiliated to Fudan University
    Oct 3, 2022

    Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

    Recruiting
    • Metastatic Colorectal Cancer (Mcrc)
    • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Advanced Pancreatic Cancer and Cholangiocarcinoma Trial in Hangzhou (PRRT with 177Lu-EB-FAPI)

    Recruiting
    • Advanced Pancreatic Cancer and Cholangiocarcinoma
    • PRRT with 177Lu-EB-FAPI
    • Hangzhou, Zhejiang, China
      First Affiliated Hospital of Zhejiang University
    Oct 10, 2023

    Minimally Invasive Pancreatoduodenectomy for Distal

    Completed
    • Distal Cholangiocarcinoma
    • Minimally invasive pancreatoduodenectomy
    • Brescia, Italy
      Fondazione Poliambulanza Istituto Ospedaliero
    Jul 27, 2022

    Multi-Platform Profiling of Resected Biliary Tract Cancer

    Recruiting
    • Biliary Tract Cancer
    • +7 more
    • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
    • Chicago, Illinois
    • +1 more
    Jan 23, 2023